Your browser doesn't support javascript.
loading
The OncoSim-Breast Cancer Microsimulation Model.
Yong, Jean H E; Nadeau, Claude; Flanagan, William M; Coldman, Andrew J; Asakawa, Keiko; Garner, Rochelle; Fitzgerald, Natalie; Yaffe, Martin J; Miller, Anthony B.
Afiliação
  • Yong JHE; Canadian Partnership Against Cancer, Toronto, ON M5H 1J8, Canada.
  • Nadeau C; Statistics Canada, Ottawa, ON K1A 0T6, Canada.
  • Flanagan WM; Statistics Canada, Ottawa, ON K1A 0T6, Canada.
  • Coldman AJ; British Columbia Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.
  • Asakawa K; Statistics Canada, Ottawa, ON K1A 0T6, Canada.
  • Garner R; Statistics Canada, Ottawa, ON K1A 0T6, Canada.
  • Fitzgerald N; Canadian Partnership Against Cancer, Toronto, ON M5H 1J8, Canada.
  • Yaffe MJ; Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.
  • Miller AB; Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5T 3M7, Canada.
Curr Oncol ; 29(3): 1619-1633, 2022 03 03.
Article em En | MEDLINE | ID: mdl-35323336
ABSTRACT

BACKGROUND:

OncoSim-Breast is a Canadian breast cancer simulation model to evaluate breast cancer interventions. This paper aims to describe the OncoSim-Breast model and how well it reproduces observed breast cancer trends.

METHODS:

The OncoSim-Breast model simulates the onset, growth, and spread of invasive and ductal carcinoma in situ tumours. It combines Canadian cancer incidence, mortality, screening program, and cost data to project population-level outcomes. Users can change the model input to answer specific questions. Here, we compared its projections with observed data. First, we compared the model's projected breast cancer trends with the observed data in the Canadian Cancer Registry and from Vital Statistics. Next, we replicated a screening trial to compare the model's projections with the trial's observed screening effects.

RESULTS:

OncoSim-Breast's projected incidence, mortality, and stage distribution of breast cancer were close to the observed data in the Canadian Cancer Registry and from Vital Statistics. OncoSim-Breast also reproduced the breast cancer screening effects observed in the UK Age trial.

CONCLUSIONS:

OncoSim-Breast's ability to reproduce the observed population-level breast cancer trends and the screening effects in a randomized trial increases the confidence of using its results to inform policy decisions related to early detection of breast cancer.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma Intraductal não Infiltrante Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Female / Humans País/Região como assunto: America do norte Idioma: En Revista: Curr Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma Intraductal não Infiltrante Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Female / Humans País/Região como assunto: America do norte Idioma: En Revista: Curr Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá